secwatch / observer
8-K filed February 3, 2025, 6:59 PM ET CIK 0001850838
other material confidence high sentiment negative materiality 1.00

Omega Therapeutics enters RSA for Chapter 11, plans asset sale after loan default

Omega Therapeutics, Inc.

item 1.01item 1.02item 2.03item 3.01item 5.02item 8.01

Machine-readable event card

schema_version
secwatch.filing_event.v1
accession
0001193125-25-019359
form_type
8-K
ticker
null
cik
0001850838
company_name
Omega Therapeutics, Inc.
filed_at
2025-02-03T23:59:59+00:00
discovered_at
2026-05-14T18:03:05.298638+00:00
generated_at
2026-05-27T04:07:28.899154+00:00
sec_items
["1.01", "1.02", "2.03", "3.01", "5.02", "8.01"]
event_type
other_material
sentiment
negative
materiality_score
1.0
calibrated_materiality_score
1.0
confidence
high
secwatch_canonical_url
https://secwatch.observer/filing/0001193125-25-019359
json_url
https://secwatch.observer/filing/0001193125-25-019359.json
markdown_url
https://secwatch.observer/filing/0001193125-25-019359.md
text_url
https://secwatch.observer/filing/0001193125-25-019359.txt
edgar_index_url
https://www.sec.gov/Archives/edgar/data/1850838/000119312525019359/0001193125-25-019359-index.htm
edgar_primary_document_url
https://www.sec.gov/Archives/edgar/data/1850838/000119312525019359/d927659d8k.htm
generated_by_model
deepseek-v4-flash:cloud@v2
review_status
machine_generated
human_reviewed
false
corrected
false
correction_note
null
correction_timestamp
null
superseded_by
null
JSON Markdown Plain text

Source-grounded claims

ad378de7f5d1c163ab582bba9bb8e2e768283c94

Omega Therapeutics, Inc. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5450(a)(1)).

January 29, 2025, the Company received a written notice (the “Notice”) from The Nasdaq Stock Market, LLC (“Nasdaq”) notifying the Company that for the last 30 consecutive business days, the bid price for the Company’s co

SEC 8-K Item 3.01 confidence 0.9 SEC evidence

Comparable filings

XXI

Tether International acquires SoftBank's stake in Twenty One Capital; board members resign

Twenty One Capital, Inc. May 20, 2026, 8:49 AM ET other_material Items 1.02, 3.01, 5.02, 8.01, 9.01

same fact type: exchange_compliance_notice same SEC item: 1.02, 3.01, 5.02, 8.01 same event type: other_material similar materiality

This filing

January 29, 2025, the Company received a written notice (the “Notice”) from The Nasdaq Stock Market, LLC (“Nasdaq”) notifying the Company that for the last 30 consecutive business days, the bid price for the Company’s co

Comparable filing

o independent directors, the minimum number required during the transition period for compliance with Section 303A.07(a) of the NYSE Listed Company Manual, as provided in Section 303A.00 of the NYSE Listed Company Manual

Filing page SEC filing

RVPH

Reviva Pharmaceuticals to be delisted from Nasdaq May 14, 2026; will trade on OTCQB

REVIVA PHARMACEUTICALS HOLDINGS, INC. May 13, 2026, 8:03 AM ET other_material Items 3.01, 8.01

same fact type: exchange_compliance_notice same SEC item: 3.01, 8.01 same event type: other_material similar materiality

This filing

January 29, 2025, the Company received a written notice (the “Notice”) from The Nasdaq Stock Market, LLC (“Nasdaq”) notifying the Company that for the last 30 consecutive business days, the bid price for the Company’s co

Comparable filing

May 12, 2026 indicating that the Panel had determined to delist the Company’s common stock from Nasdaq. The Company’s common stock will be suspended from trading on Nasdaq as of the open of trading on May 14, 2026. Begin

Filing page SEC filing

SOPA

Society Pass receives Nasdaq delisting notice after filing Chapter 11 bankruptcy

SOCIETY PASS INCORPORATED. May 20, 2026, 6:05 AM ET other_material Items 3.01

same fact type: exchange_compliance_notice same SEC item: 3.01 same event type: other_material similar materiality

This filing

January 29, 2025, the Company received a written notice (the “Notice”) from The Nasdaq Stock Market, LLC (“Nasdaq”) notifying the Company that for the last 30 consecutive business days, the bid price for the Company’s co

Comparable filing

May 14, 2026, the Company was notified by the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) that Nasdaq had determined to delist the Company’s common stock, par value $0.0001 per share (the

Filing page SEC filing

BTM

Bitcoin Depot files Chapter 11; Nasdaq to suspend BTM stock and warrants on May 26

Bitcoin Depot Inc. May 19, 2026, 4:01 PM ET other_material Items 3.01

same fact type: exchange_compliance_notice same SEC item: 3.01 same event type: other_material similar materiality

This filing

January 29, 2025, the Company received a written notice (the “Notice”) from The Nasdaq Stock Market, LLC (“Nasdaq”) notifying the Company that for the last 30 consecutive business days, the bid price for the Company’s co

Comparable filing

May 18, 2026, the Company received a letter from the Listing Qualifications Department staff of the Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that, as a result of the Debtors’ commencement of the Chapter 1

Filing page SEC filing

BKYI

BIO-key receives Nasdaq delisting notice; stock to move to OTC Markets on May 13

BIO KEY INTERNATIONAL INC May 12, 2026, 4:46 PM ET other_material Items 3.01, 7.01, 9.01

same fact type: exchange_compliance_notice same SEC item: 3.01 same event type: other_material similar materiality

This filing

January 29, 2025, the Company received a written notice (the “Notice”) from The Nasdaq Stock Market, LLC (“Nasdaq”) notifying the Company that for the last 30 consecutive business days, the bid price for the Company’s co

Comparable filing

May 6, 2026, BIO-key International, Inc. (the “ Company ”) received notice from the staff of The Nasdaq Stock Market, LLC (“ Nasdaq ”) stating that the Company had not regained compliance with Nasdaq Listing Rule 5550(a)

Filing page SEC filing

ISPC

iSpecimen prices $2.5M private placement at $5.12/share; regains Nasdaq minimum bid price compliance

iSpecimen Inc. May 13, 2026, 5:00 PM ET other_material Items 1.01, 3.01, 3.02, 7.01, 8.01, 9.01

same fact type: exchange_compliance_notice same SEC item: 1.01, 3.01, 8.01 same event type: other_material

This filing

January 29, 2025, the Company received a written notice (the “Notice”) from The Nasdaq Stock Market, LLC (“Nasdaq”) notifying the Company that for the last 30 consecutive business days, the bid price for the Company’s co

Comparable filing

minimum $1.00 per share required for continued listing on The Nasdaq Capital Market under Nasdaq Listing Rule 5550(a)(2) (the “Minimum Bid Price Requirement”) for the prior 30 consecutive business days. On May 12, 2026

Filing page SEC filing

DRCT

DRCT enters $50M equity line with Roth, terminates New Circle ELOC, receives Nasdaq delisting notice

Direct Digital Holdings, Inc. April 28, 2026, 7:59 PM ET other_material Items 1.01, 1.02, 3.01, 3.03, 5.03, 9.01

same fact type: exchange_compliance_notice same SEC item: 1.01, 1.02, 3.01 same event type: other_material

This filing

January 29, 2025, the Company received a written notice (the “Notice”) from The Nasdaq Stock Market, LLC (“Nasdaq”) notifying the Company that for the last 30 consecutive business days, the bid price for the Company’s co

Comparable filing

April 23, 2026, the Company received an Additional Staff Delisting Determination Letter from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“ Nasdaq ”), notifying the Company that it is not in comp

Filing page SEC filing

PMI

Picard Medical raises $5M in public offering, receives NYSE American delisting notice for low equity

Picard Medical, Inc. May 11, 2026, 5:08 PM ET other_material Items 1.01, 3.01, 9.01

same fact type: exchange_compliance_notice same SEC item: 1.01, 3.01 same event type: other_material

This filing

January 29, 2025, the Company received a written notice (the “Notice”) from The Nasdaq Stock Market, LLC (“Nasdaq”) notifying the Company that for the last 30 consecutive business days, the bid price for the Company’s co

Comparable filing

May 8, 2026, the Company received a written notice (the “Notice”) from the NYSE American LLC (the “NYSE American”) indicating that the Company is not in compliance with the NYSE American continued listing standards set forth in Section 1003(a)(ii) of the NYSE American Company Guide (the “Company Guide”) requiring a company to have stockholders’ equity of at least $4.0 million if it has reported losses from continuing operations and/or net losses in three of its four most recent fiscal years. The Notice states that the Company reported a stockholders’ equity of approximately $3.8 million as of

Filing page SEC filing

Source: SEC EDGAR
accession 0001193125-25-019359
view filing index on sec.gov
view primary document

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.